Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

View:
Post by Whyme16 on Jul 27, 2021 5:11pm

B Warrants

I called TD Waterhouse and was on the phone with them for 45 minutes. They dis RS to both my regular CLAS shares and the B warrants. I tried to explain to them that my understanding is that the number of B warrant shares shouldn't have been impacted by the RS and one should need 20 of them to purchase 1 CLAS share but they didn't understand and not even willing to look into it!!

Does anyone else has the same problem? with the RS to B warrants I've lost 90% of my warrants value over night! This doesn't make sense to me!
Comment by Rocdog on Jul 27, 2021 6:02pm
yes i had the same problem and i made them go back and open an investigation otherwise i threatened to sue them.  they are looking into it now.  i would do the same otherwise we all lose 95% of out value right off the bat which is not correct
Comment by Whyme16 on Jul 28, 2021 11:10am
anyone here who does not use TD and hold B warrants? I need confirmation if your B warrant is still the same number as they were from before the R/S or not and which institution you are with - TD insists that they did it right by doing a R/S on the B warrants as well and wiping out 95% of all of our accounts in one shot!! Please confirm. Whyme16 - (7/27/2021 5:11:20 PM) B Warrants I ...more  
Comment by PowerLeopard on Jul 28, 2021 12:26pm
I am currently on hold with TD... Again. Buddy on the other end of the phone says that the warrants should also go through the split. I insisted that he is wrong, and so he is on hold with someone else to get an official answer regarding that. He doesn't seem to want to help, and doesn't agree with me obviously, but not enough to say I'm wrong. Been on hold 26minutes now
Comment by PowerLeopard on Jul 28, 2021 1:11pm
They are telling me the warrants get split 20:1 but are convertible 1:1 still. I told them I want to exercise all my warrants then. NOW they are looking into it further
Comment by PowerLeopard on Jul 28, 2021 1:20pm
Their official response is that they have made no mistake. And they cannot confirm the exercise price at this moment, as they are waiting for an update from Claritas.
Comment by bogdansz on Aug 20, 2021 1:47pm
When the B warrants expire? Anyone ?
Comment by Red~One on Aug 20, 2021 1:58pm
26 April 2022
Comment by PJ44853783 on Aug 20, 2021 2:37pm
April 26, 2022
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities